Tumor necrosis factor/cachectin is an effector of skin and gut lesions of the acute phase of graft-vs.-host disease

doi:10.1084/jem.166.5.1280

This Article

	Full Text (PDF, 771K)
	Alert me when this article is cited
	Citation Map

Services

	Email this article
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new content in the JEM
	Download to citation manager

Citing Articles

	Citing Articles via HighWire
	Citing Articles via CrossRef
	Citing Articles via Google Scholar

Google Scholar

	Articles by Piguet, P. F.
	Articles by Vassalli, P.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Piguet, P. F.
	Articles by Vassalli, P.


Social Bookmarking

	What's this?

ARTICLES

Tumor necrosis factor/cachectin is an effector of skin and gut lesions of the acute phase of graft-vs.-host disease

PF Piguet, GE Grau, B Allet and P Vassalli
Department of Pathology, University of Geneva, Centre Medical Universitaire, Switzerland.

Lethally irradiated mice were injected with semiallogeneic, T-depleted bone marrow cells and an amount of peripheral T lymphocytes sufficient to induce graft-vs.-host disease (GVHD) becoming apparent on the second week after the graft and leading to an increasing mortality rate within the following weeks (greater than 90% mortality within 80 d). Mice receiving bone marrow cells alone had no GVHD and were used as controls. Beginning on day 8, mice with GVHD were injected weekly with 2 mg of either rabbit anti-mouse recombinant tumor necrosis factor/cachectin (TNF-alpha) IgG, or normal rabbit IgG. On the 16-18th d, mice were killed to examine the skin and intestinal lesions of the acute phase of GVHD. The anti-TNF treatment resulted in an almost complete prevention of the severe lesions seen in the mice treated with normal rabbit IgG, i.e., the skin epidermal cell necrosis, foci of lichenoid hyperplastic reactions, and loss of the hypodermic fat; in the gut dilatation with marked flattening of the villi and elevation of the crypts, with increased numbers of mitoses and isolated crypt cell necrosis. In addition to preventing these acute lesions, anti-TNF treatment resulted in a significantly decreased mortality (approximately 70% survival at 80 d). These results suggest that during acute GVHD, the activation of grafted lymphocytes leads to a local release of TNF in the cutaneous and intestinal mucosae, which induces epithelial cell alterations and increases the inflammatory reaction.
Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Facebook Add to Reddit Reddit Add to Technorati Technorati Twitter What's this?

This article has been cited by other articles:

Socie, G., Blazar, B. R. (2009). Acute graft-versus-host disease: from the bench to the bedside. Blood 114: 4327-4336 [Abstract] [Full Text]
Rotolo, J. A., Stancevic, B., Lu, S. X., Zhang, J., Suh, D., King, C. G., Kappel, L. W., Murphy, G. F., Liu, C., Fuks, Z., van den Brink, M. R., Kolesnick, R. (2009). Cytolytic T cells induce ceramide-rich platforms in target cell membranes to initiate graft-versus-host disease. Blood 114: 3693-3706 [Abstract] [Full Text]
Ierna, M. X., Scales, H. E., Mueller, C., Lawrence, C. E. (2009). Transmembrane Tumor Necrosis Factor Alpha Is Required for Enteropathy and Is Sufficient To Promote Parasite Expulsion in Gastrointestinal Helminth Infection. Infect. Immun. 77: 3879-3885 [Abstract] [Full Text]
Chakraverty, R., Flutter, B., Fallah-Arani, F., Eom, H.-S., Means, T., Andreola, G., Schwarte, S., Buchli, J., Cotter, P., Zhao, G., Sykes, M. (2008). The Host Environment Regulates the Function of CD8+ Graft-versus-Host-Reactive Effector Cells. J. Immunol. 181: 6820-6828 [Abstract] [Full Text]
Yanik, G. A., Ho, V. T., Levine, J. E., White, E. S., Braun, T., Antin, J. H., Whitfield, J., Custer, J., Jones, D., Ferrara, J. L. M., Cooke, K. R. (2008). The impact of soluble tumor necrosis factor receptor etanercept on the treatment of idiopathic pneumonia syndrome after allogeneic hematopoietic stem cell transplantation. Blood 112: 3073-3081 [Abstract] [Full Text]
Beilhack, A., Schulz, S., Baker, J., Beilhack, G. F., Nishimura, R., Baker, E. M., Landan, G., Herman, E. I., Butcher, E. C., Contag, C. H., Negrin, R. S. (2008). Prevention of acute graft-versus-host disease by blocking T-cell entry to secondary lymphoid organs. Blood 111: 2919-2928 [Abstract] [Full Text]
Levine, J. E., Paczesny, S., Mineishi, S., Braun, T., Choi, S. W., Hutchinson, R. J., Jones, D., Khaled, Y., Kitko, C. L., Bickley, D., Krijanovski, O., Reddy, P., Yanik, G., Ferrara, J. L. M. (2008). Etanercept plus methylprednisolone as initial therapy for acute graft-versus-host disease. Blood 111: 2470-2475 [Abstract] [Full Text]
Dutt, S., Tseng, D., Ermann, J., George, T. I., Liu, Y. P., Davis, C. R., Fathman, C. G., Strober, S. (2007). Naive and Memory T Cells Induce Different Types of Graft-versus-Host Disease. J. Immunol. 179: 6547-6554 [Abstract] [Full Text]
Ramirez-Montagut, T., Chow, A., Kochman, A. A., Smith, O. M., Suh, D., Sindhi, H., Lu, S., Borsotti, C., Grubin, J., Patel, N., Terwey, T. H., Kim, T. D., Heller, G., Murphy, G. F., Liu, C., Alpdogan, O., van den Brink, M. R. M. (2007). IFN-{gamma} and Fas Ligand Are Required for Graft-versus-Tumor Activity against Renal Cell Carcinoma in the Absence of Lethal Graft-versus-Host Disease. J. Immunol. 179: 1669-1680 [Abstract] [Full Text]
Borsotti, C., Franklin, A. R. K., Lu, S. X., Kim, T. D., Smith, O. M., Suh, D., King, C. G., Chow, A., Liu, C., Alpdogan, O., van den Brink, M. R. M. (2007). Absence of donor T-cell-derived soluble TNF decreases graft-versus-host disease without impairing graft-versus-tumor activity. Blood 110: 783-786 [Abstract] [Full Text]
Chakraverty, R., Sykes, M. (2007). The role of antigen-presenting cells in triggering graft-versus-host disease and graft-versus-leukemia. Blood 110: 9-17 [Abstract] [Full Text]
Mohty, M., Blaise, D., Faucher, C., Vey, N., Bouabdallah, R., Stoppa, A.-M., Viret, F., Gravis, G., Olive, D., Gaugler, B. (2005). Inflammatory cytokines and acute graft-versus-host disease after reduced-intensity conditioning allogeneic stem cell transplantation. Blood 106: 4407-4411 [Abstract] [Full Text]
El-Hayek, J. M., Rogers, T. E., Brown, G. R. (2005). The role of TNF in hepatic histopathological manifestations and hepatic CD8+ T cell alloresponses in murine MHC class I disparate GVHD. J. Leukoc. Biol. 78: 1001-1007 [Abstract] [Full Text]
Shukla, M., Yang, S., Milla, C., Panoskaltsis-Mortari, A., Blazar, B. R., Haddad, I. Y. (2005). Absence of host tumor necrosis factor receptor 1 attenuates manifestations of idiopathic pneumonia syndrome. Am. J. Physiol. Lung Cell. Mol. Physiol. 288: L942-L949 [Abstract] [Full Text]
Iwasaki, T. (2004). Recent Advances in the Treatment of Graft-Versus-Host Disease. Clin Med Res 2: 243-252 [Abstract] [Full Text]
Hildebrandt, G. C., Olkiewicz, K. M., Corrion, L. A., Chang, Y., Clouthier, S. G., Liu, C., Cooke, K. R. (2004). Donor-derived TNF-{alpha} regulates pulmonary chemokine expression and the development of idiopathic pneumonia syndrome after allogeneic bone marrow transplantation. Blood 104: 586-593 [Abstract] [Full Text]
Clark, I. A., Alleva, L. M., Mills, A. C., Cowden, W. B. (2004). Pathogenesis of Malaria and Clinically Similar Conditions. Clin. Microbiol. Rev. 17: 509-539 [Abstract] [Full Text]
Ertault-Daneshpouy, M., Leboeuf, C., Lemann, M., Bouhidel, F., Ades, L., Gluckman, E., Socie, G., Janin, A. (2004). Pericapillary hemorrhage as criterion of severe human digestive graft-versus-host disease. Blood 103: 4681-4684 [Abstract] [Full Text]
Yamamoto, S., Tsuji, T., Matsuzaki, J., Zhange, Y., Chamoto, K., Kosaka, A., Togashi, Y., Sekikawa, K., Sawada, K.-i., Takeshima, T., Koike, T., Nishimura, T. (2004). Unexpected role of TNF-{alpha} in graft versus host reaction (GVHR): donor-derived TNF-{alpha} suppresses GVHR via inhibition of IFN-{gamma}-dependent donor type-1 immunity. Int Immunol 16: 811-817 [Abstract] [Full Text]
Socie, G., Mary, J.-Y., Lemann, M., Daneshpouy, M., Guardiola, P., Meignin, V., Ades, L., Esperou, H., Ribaud, P., Devergie, A., Gluckman, E., Ameisen, J.-C., Janin, A. (2004). Prognostic value of apoptotic cells and infiltrating neutrophils in graft-versus-host disease of the gastrointestinal tract in humans: TNF and Fas expression. Blood 103: 50-57 [Abstract] [Full Text]
Ansell, B. J., Navab, M., Hama, S., Kamranpour, N., Fonarow, G., Hough, G., Rahmani, S., Mottahedeh, R., Dave, R., Reddy, S. T., Fogelman, A. M. (2003). Inflammatory/Antiinflammatory Properties of High-Density Lipoprotein Distinguish Patients From Control Subjects Better Than High-Density Lipoprotein Cholesterol Levels and Are Favorably Affected by Simvastatin Treatment. Circulation 108: 2751-2756 [Abstract] [Full Text]
Ichiba, T., Teshima, T., Kuick, R., Misek, D. E., Liu, C., Takada, Y., Maeda, Y., Reddy, P., Williams, D. L., Hanash, S. M., Ferrara, J. L. M. (2003). Early changes in gene expression profiles of hepatic GVHD uncovered by oligonucleotide microarrays. Blood 102: 763-771 [Abstract] [Full Text]
Schmaltz, C., Alpdogan, O., Muriglan, S. J., Kappel, B. J., Rotolo, J. A., Ricchetti, E. T., Greenberg, A. S., Willis, L. M., Murphy, G. F., Crawford, J. M., van den Brink, M. R. M. (2003). Donor T cell-derived TNF is required for graft-versus-host disease and graft-versus-tumor activity after bone marrow transplantation. Blood 101: 2440-2445 [Abstract] [Full Text]
Cooke, K. R., Olkiewicz, K., Erickson, N., Ferrara, J. L.M. (2002). The role of endotoxin and the innate immune response in the pathophysiology of acute graft versus host disease. Innate Immunity 8: 441-448 [Abstract]
Pinkoski, M. J., Droin, N. M., Green, D. R. (2002). Tumor Necrosis Factor alpha Up-regulates Non-lymphoid Fas-ligand following Superantigen-induced Peripheral Lymphocyte Activation. J. Biol. Chem. 277: 42380-42385 [Abstract] [Full Text]
Liu, J., Heuer, J. G., Na, S., Galbreath, E., Zhang, T., Yang, D. D., Glasebrook, A., Song, H. Y. (2002). Accelerated Onset and Increased Severity of Acute Graft-Versus-Host Disease Following Adoptive Transfer of DR6-Deficient T Cells. J. Immunol. 169: 3993-3998 [Abstract] [Full Text]
Spies, M., Chappell, V. L., Dasu, M. R., Herndon, D. N., Thompson, J. C., Wolf, S. E. (2002). Role of TNF-alpha in gut mucosal changes after severe burn. Am. J. Physiol. Gastrointest. Liver Physiol. 283: G703-G708 [Abstract] [Full Text]
Sugerman, P.B., Savage, N.W., Walsh, L.J., Zhao, Z.Z., Zhou, X.J., Khan, A., Seymour, G.J., Bigby, M. (2002). THE PATHOGENESIS OF ORAL LICHEN PLANUS. CROBM 13: 350-365 [Abstract] [Full Text]
Brown, G. R., Lee, E., Thiele, D. L. (2002). TNF-TNFR2 Interactions Are Critical for the Development of Intestinal Graft-Versus-Host Disease in MHC Class II-Disparate (C57BL/6J->C57BL/6J x bm12)F1 Mice. J. Immunol. 168: 3065-3071 [Abstract] [Full Text]
Chen, B. J., Cui, X., Chao, N. J. (2002). Addition of a second, different allogeneic graft accelerates white cell and platelet engraftment after T-cell-depleted bone marrow transplantation. Blood 99: 2235-2240 [Abstract] [Full Text]
Chen, B. J., Cui, X., Sempowski, G. D., Gooding, M. E., Liu, C., Haynes, B. F., Chao, N. J. (2002). A comparison of murine T-cell-depleted adult bone marrow and full-term fetal blood cells in hematopoietic engraftment and immune reconstitution. Blood 99: 364-371 [Abstract] [Full Text]
Matsue, H., Matsue, K., Kusuhara, M., Kumamoto, T., Okumura, K., Yagita, H., Takashima, A. (2001). Immunosuppressive properties of CD95L-transduced "killer" hybrids created by fusing donor- and recipient-derived dendritic cells. Blood 98: 3465-3472 [Abstract] [Full Text]
Snider, D., Liang, H. (2001). Early Intestinal Th1 Inflammation and Mucosal T Cell Recruitment During Acute Graft-Versus-Host Reaction. J. Immunol. 166: 5991-5999 [Abstract] [Full Text]
Schmaltz, C., Alpdogan, O., Horndasch, K. J., Muriglan, S. J., Kappel, B. J., Teshima, T., Ferrara, J. L. M., Burakoff, S. J., van den Brink, M. R. M. (2001). Differential use of Fas ligand and perforin cytotoxic pathways by donor T cells in graft-versus-host disease and graft-versus-leukemia effect. Blood 97: 2886-2895 [Abstract] [Full Text]
Drobyski, W. R., Morse, H. C. III, Burns, W. H., Casper, J. T., Sandford, G. (2001). Protection from lethal murine graft-versus-host disease without compromise of alloengraftment using transgenic donor T cells expressing a thymidine kinase suicide gene. Blood 97: 2506-2513 [Abstract] [Full Text]
Cooke, K. R., Hill, G. R., Gerbitz, A., Kobzik, L., Martin, T. R., Crawford, J. M., Brewer, J. P., Ferrara, J. L. M. (2000). Hyporesponsiveness of Donor Cells to Lipopolysaccharide Stimulation Reduces the Severity of Experimental Idiopathic Pneumonia Syndrome: Potential Role for a Gut-Lung Axis of Inflammation. J. Immunol. 165: 6612-6619 [Abstract] [Full Text]
Hsieh, M. H., Korngold, R. (2000). Differential use of FasL- and perforin-mediated cytolytic mechanisms by T-cell subsets involved in graft-versus-myeloid leukemia responses. Blood 96: 1047-1055 [Abstract] [Full Text]
Hill, G. R., Ferrara, J. L. M. (2000). The primacy of the gastrointestinal tract as a target organ of acute graft-versus-host disease: rationale for the use of cytokine shields in allogeneic bone marrow transplantation. Blood 95: 2754-2759 [Abstract] [Full Text]
Tsukada, N., Akiba, H., Kobata, T., Aizawa, Y., Yagita, H., Okumura, K. (2000). Blockade of CD134 (OX40)-CD134L interaction ameliorates lethal acute graft-versus-host disease in a murine model of allogeneic bone marrow transplantation. Blood 95: 2434-2439 [Abstract] [Full Text]
Chen, Y., Zeng, D., Schlegel, P. G., Fidler, J., Chao, N. J. (2000). PG27, an extract of Tripterygium wilfordii hook f, induces antigen-specific tolerance in bone marrow transplantation in mice. Blood 95: 705-710 [Abstract] [Full Text]
van den Brink, M. R. M., Moore, E., Horndasch, K. J., Crawford, J. M., Hoffman, J., Murphy, G. F., Burakoff, S. J. (2000). Fas-Deficient lpr Mice Are More Susceptible to Graft-Versus-Host Disease. J. Immunol. 164: 469-480 [Abstract] [Full Text]
Kapelushnik, J., Weiss, L., Pappo, O., Okon, E., Or, R. (1999). Thalidomide does not interfere with graft-versus-leukemia reactivity in mice. J Oncol Pharm Pract 5: 179-183 [Abstract]
Cavet, J., Middleton, P. G., Segall, M., Noreen, H., Davies, S. M., Dickinson, A. M. (1999). Recipient Tumor Necrosis Factor-alpha and Interleukin-10 Gene Polymorphisms Associate With Early Mortality and Acute Graft-Versus-Host Disease Severity in HLA-Matched Sibling Bone Marrow Transplants. Blood 94: 3941-3946 [Abstract] [Full Text]
Stuber, E, Buschenfeld, A, von Freier, A, Arendt, T, Folsch, U R (1999). Intestinal crypt cell apoptosis in murine acute graft versus host disease is mediated by tumour necrosis factor alpha and not by the FasL-Fas interaction: effect of pentoxifylline on the development of mucosal atrophy. Gut 45: 229-235 [Abstract] [Full Text]
Pan, L., Teshima, T., Hill, G. R., Bungard, D., Brinson, Y. S., Reddy, V. S., Cooke, K. R., Ferrara, J. L.M. (1999). Granulocyte Colony-Stimulating Factor-Mobilized Allogeneic Stem Cell Transplantation Maintains Graft-Versus-Leukemia Effects Through a Perforin-Dependent Pathway While Preventing Graft-Versus-Host Disease. Blood 93: 4071-4078 [Abstract] [Full Text]
van Meerwijk, J. P.M., MacDonald, H. R. (1999). In Vivo T-Lymphocyte Tolerance in the Absence of Thymic Clonal Deletion Mediated by Hematopoietic Cells. Blood 93: 3856-3862 [Abstract] [Full Text]
Beelen, D. W., Elmaagacli, A., Muller, K.-D., Hirche, H., Schaefer, U. W. (1999). Influence of Intestinal Bacterial Decontamination Using Metronidazole and Ciprofloxacin or Ciprofloxacin Alone on the Development of Acute Graft-Versus-Host Disease After Marrow Transplantation in Patients With Hematologic Malignancies: Final Results and Long-Term Follow-Up of an Open-Label Prospective Randomized Trial. Blood 93: 3267-3275 [Abstract] [Full Text]
Tsukada, N., Kobata, T., Aizawa, Y., Yagita, H., Okumura, K. (1999). Graft-Versus-Leukemia Effect and Graft-Versus-Host Disease Can Be Differentiated by Cytotoxic Mechanisms in a Murine Model of Allogeneic Bone Marrow Transplantation. Blood 93: 2738-2747 [Abstract] [Full Text]
Daum, S, Bauer, U, Foss, H-D, Schuppan, D, Stein, H, Riecken, E-O, Ullrich, R (1999). Increased expression of mRNA for matrix metalloproteinases-1 and -3�and tissue inhibitor of metalloproteinases-1 in intestinal biopsy specimens from patients with coeliac disease. Gut 44: 17-25 [Abstract] [Full Text]
Yu, X.-Z., Martin, P. J., Anasetti, C. (1998). Role of CD28 in Acute Graft-Versus-Host Disease. Blood 92: 2963-2970 [Abstract] [Full Text]
Drobyski, W. R., Majewski, D., Ozker, K., Hanson, G. (1998). Ex Vivo Anti-CD3 Antibody-Activated Donor T Cells Have a Reduced Ability to Cause Lethal Murine Graft-Versus-Host Disease but Retain Their Ability to Facilitate Alloengraftment. J. Immunol. 161: 2610-2619 [Abstract] [Full Text]
Ellison, C. A., Fischer, J. M. M., HayGlass, K. T., Gartner, J. G. (1998). Murine Graft-Versus-Host Disease in an F1-Hybrid Model Using IFN-{gamma} Gene Knockout Donors. J. Immunol. 161: 631-640 [Abstract] [Full Text]
Mori, T., Nishimura, T., Ikeda, Y., Hotta, T., Yagita, H., Ando, K. (1998). Involvement of Fas-Mediated Apoptosis in the Hematopoietic Progenitor Cells of Graft-Versus-Host Reaction-Associated Myelosuppression. Blood 92: 101-107 [Abstract] [Full Text]
Hattori, K., Hirano, T., Miyajima, H., Yamakawa, N., Tateno, M., Oshimi, K., Kayagaki, N., Yagita, H., Okumura, K. (1998). Differential Effects of Anti-Fas Ligand and Anti-Tumor Necrosis Factor alpha �Antibodies on Acute Graft-Versus-Host Disease Pathologies. Blood 91: 4051-4055 [Abstract] [Full Text]
Aractingi, S., Chosidow, O. (1998). Cutaneous Graft-versus-Host Disease. Arch Dermatol 134: 602-612 [Abstract] [Full Text]
Ehl, S., Hombach, J., Aichele, P., Rulicke, T., Odermatt, B., Hengartner, H., Zinkernagel, R., Pircher, H. (1998). Viral and Bacterial Infections Interfere with Peripheral Tolerance Induction and Activate CD8+ T Cells to Cause Immunopathology. JEM 187: 763-774 [Abstract] [Full Text]
Shankar, G., Scott Bryson, J., Darrell Jennings, C., Morris, P. E., Cohen, D. A. (1998). Idiopathic Pneumonia Syndrome in Mice after Allogeneic Bone Marrow Transplantation. Am. J. Respir. Cell Mol. Bio. 18: 235-242 [Abstract] [Full Text]
Hill, G. R., Crawford, J. M., Cooke, K. R., Brinson, Y. S., Pan, L., Ferrara, J. L.M. (1997). Total Body Irradiation and Acute Graft-Versus-Host Disease: The Role of Gastrointestinal Damage and Inflammatory Cytokines. Blood 90: 3204-3213 [Abstract] [Full Text]
Hattori, K., Hirano, T., Ushiyama, C., Miyajima, H., Yamakawa, N., Ebata, T., Wada, Y., Ikeda, S., Yoshino, K., Tateno, M., Oshimi, K., Kayagaki, N., Yagita, H., Okumura, K. (1997). A Metalloproteinase Inhibitor Prevents Lethal Acute Graft-Versus-Host Disease in Mice. Blood 90: 542-548 [Abstract] [Full Text]
Woo, S.-B., Lee, S. J., Schubert, M. M. (1997). Graft-vs.-Host Disease. CROBM 8: 201-216 [Abstract] [Full Text]
Kr�mer, B., Wiegmann, K., Kr�nke, M. (1995). Regulation of the Human TNF Promoter by the Transcription Factor Ets. J. Biol. Chem. 270: 6577-6583 [Abstract] [Full Text]
Cheng, J, Turksen, K, Yu, Q C, Schreiber, H, Teng, M, Fuchs, E (1992). Cachexia and graft-vs.-host-disease-type skin changes in keratin promoter-driven TNF alpha transgenic mice.. Genes Dev. 6: 1444-1456 [Abstract]
Mintz, M., Rapaport, R., Oleske, J. M., Connor, E. M., Koenigsberger, M. R., Denny, T., Epstein, L. G. (1989). Elevated Serum Levels of Tumor Necrosis Factor Are Associated With Progressive Encephalopathy in Children With Acquired Immunodeficiency Syndrome. Arch Pediatr Adolesc Med 143: 771-774 [Abstract]